有価証券及び投資有価証券売却益、資本合計、セグメント利益（△損失） - 医薬
- 【期間】
| 年度 | 有価証券及び投資有価証券売却益 | 資本合計 | セグメント利益（△損失） - 医薬 |
|---|
| 2018/12 | - | | 1.19兆 | | 504億 | |
| 2019/03 | - | | - | | 175億 | -65.3% |
| 2019/06 | - | | - | | 326億 | +86.4% |
| 2019/09 | - | | - | | 466億 | +43% |
| 2019/12 | - | | 1.15兆 | -3.7% | 554億 | +18.8% |
| 2020/03 | - | | 1.02兆 | -10.8% | 164億 | -70.4% |
| 2020/06 | - | | 1.06兆 | +3.4% | 346億 | +111% |
| 2020/09 | - | | 1.08兆 | +1.9% | 502億 | +45.2% |
| 2020/12 | - | | 1.1兆 | +1.7% | 590億 | +17.5% |
| 2021/03 | - | | 1.13兆 | +3% | 149億 | -74.8% |
| 2021/06 | - | | 1.14兆 | +0.9% | 301億 | +101.8% |
| 2021/09 | - | | 1.12兆 | -1.6% | 456億 | +51.6% |
| 2021/12 | - | | 1.15兆 | +2.5% | 612億 | +34.2% |
| 2022/03 | - | | 1.19兆 | +4.1% | 159億 | -74% |
| 2022/06 | - | | 1.26兆 | +5.4% | 376億 | +136% |
| 2022/09 | - | | 1.31兆 | +3.7% | 583億 | +55.1% |
| 2022/12 | - | | 1.25兆 | -4.1% | 825億 | +41.5% |
| 2023/03 | - | | 1.23兆 | -1.7% | 162億 | -80.4% |
| 2023/06 | - | | 1.33兆 | +8.2% | 361億 | +123% |
| 2023/09 | - | | 1.39兆 | +4.7% | 589億 | +63.2% |
| 2023/12 | - | | 1.43兆 | +2.2% | 960億 | +62.8% |
| 2024/03 | - | | 1.46兆 | +2.2% | 165億 | -82.8% |
| 2024/06 | - | | 1.59兆 | +9% | 411億 | +148.7% |
